BCAB- Bioatla, Inc.

Name: Bioatla, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Bioatla, Inc. (BCAB) has 4 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. BCAB is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Short Jay M Phd	2.66M	$9.72M	-
Other	Sievers Eric	598.7K	$2.19M	-
CFO	Vasquez Christian	530.2K	$1.94M	-
CFO	Waldron Richard A	343.4K	$1.26M	-

Activity

Buys and sells only

Transactions

10 filings · page 4

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Oct 1, 2021	Smith Scott Andrew94	President	Sell	2,994	$30.18	$90,351.44	-0.8%	-34.4%	-75.1%
Oct 1, 2021	Sievers Eric91	Chief Medical Officer	Sell	592	$30.39	$17,993.43	-0.6%	-34.4%	-75.1%
Sep 15, 2021	Steinman Lawrence64	Director	Sell	450	$36.82	$16,569.00	-2.3%	-43.7%	-76.8%
Aug 26, 2021	Smith Scott Andrew94	President	Sell	33,244	$40.16	$1,334,926.93	-4.4%	-33.2%	-76.4%
Aug 26, 2021	Sievers Eric91	Chief Medical Officer	Sell	6,883	$39.59	$272,495.91	-6.8%	-33.2%	-76.4%
Aug 24, 2021	Short Jay M Phd87	Chief Executive Officer	Sale+OE	4,533	$41.60	$188,572.80	-0.6%	-38.5%	-78.2%
Aug 24, 2021	Levy Guy	Director	Sell	546,709	$39.65	$21,677,011.85	-19.7%	-38.5%	-78.2%
Aug 16, 2021	Steinman Lawrence64	Director	Sell	450	$40.60	$18,270.00	-2.3%	-32.0%	-70.3%
Jul 15, 2021	Steinman Lawrence64	Director	Sell	450	$38.29	$17,230.50	-2.2%	-27.3%	-88.9%
Jun 21, 2021	Short Jay M Phd87	Chief Executive Officer	Sell	74,269	$39.16	$2,908,126.10	-2.2%	-15.3%	-92.8%

← PrevPage 4Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC